IL6 and prostate cancer: Another multiplexed platform that was reported for prostate cancer biomarkers was from Tang et al. This group adapted an array of 32 electrochemical sensors to detect four different biomarkers for prostate cancer, which were prostate-specific antigen, prostate-specific membrane antigen, interleukin-6 (IL-6), and platelet factor-4 (PF-4) (Figure 4d).